Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.

Fulltext:
155026.pdf
Embargo:
until further notice
Size:
1.069Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2015Source
Radiotherapy and Oncology, 115, 2, (2015), pp. 163-170ISSN
Annotation
1 mei 2015
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Oral and Maxillofacial Surgery
Journal title
Radiotherapy and Oncology
Volume
vol. 115
Issue
iss. 2
Page start
p. 163
Page end
p. 170
Subject
Radboudumc 10: Reconstructive and regenerative medicine RIHS: Radboud Institute for Health SciencesAbstract
PURPOSE: To explore the value of diffusion-weighted magnetic resonance imaging (DW-MRI) for the prediction of pathologic response to neoadjuvant chemoradiotherapy (nCRT) in esophageal cancer. MATERIAL AND METHODS: In 20 patients receiving nCRT for esophageal cancer DW-MRI scanning was performed before nCRT, after 8-13 fractions, and before surgery. The median tumor apparent diffusion coefficient (ADC) was determined at these three time points. The predictive potential of initial tumor ADC, and change in ADC (DeltaADC) during and after treatment for pathologic complete response (pathCR) and good response were assessed. Good response was defined as pathCR or near-pathCR (tumor regression grade [TRG] 1 or 2). RESULTS: A pathCR after nCRT was found in 4 of 20 patients (20%), and 8 patients (40%) showed a good response to nCRT. The DeltaADCduring was significantly higher in pathCR vs. non-pathCR patients (34.6%+/-10.7% [mean+/-SD] vs. 14.0%+/-13.1%, p=0.016), as well as in good vs. poor responders (30.5%+/-8.3% vs. 9.5%+/-12.5%, p=0.002). The DeltaADCduring was predictive of residual cancer at a threshold of 29% (sensitivity of 100%, specificity of 75%, PPV of 94%, and NPV of 100%), and for poor pathologic response at a threshold of 21% (sensitivity of 82%, specificity of 100%, PPV of 100%, and NPV of 80%). CONCLUSIONS: In this exploratory study, the treatment-induced change in ADC during the first 2-3weeks of nCRT for esophageal cancer seemed highly predictive of histopathologic response. Larger series are warranted to verify these results.
This item appears in the following Collection(s)
- Academic publications [205084]
- Electronic publications [103306]
- Faculty of Medical Sciences [81053]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.